therascreen IDH1/2 RGQ PCR Kit CE

For the detection of 12 IDH1 and IDH2 mutations in glioma

S_1084_5_GEN_V2

✓ 24/7 automatic processing of online orders

✓ Knowledgeable and professional Product & Technical Support

✓ Fast and reliable (re)-ordering

therascreen IDH1/2 RGQ PCR Kit (20) CE

Cat. No. / ID:   873011

For 20 reactions: 9 Primer and Probe Mixes, WT Control, Positive Control, Master Mix, Nuclease-Free Water
Inquire
The therascreen IDH1/2 RGQ PCR Kit CE is intended for in vitro diagnostic use in Europe.

✓ 24/7 automatic processing of online orders

✓ Knowledgeable and professional Product & Technical Support

✓ Fast and reliable (re)-ordering

Features

  • Compliance with EU IVD Directive 98/79/EC
  • Accurate detection of 7 IDH1 and 5 IDH2 mutations using PCR clamping
  • Sensitive identification of 3 mutations using ARMS PCR technology
  • A standardized assay with ready-to-use solutions
  • An easy workflow with the Rotor-Gene Q instrument

Product Details

The therascreen IDH1/2 RGQ PCR Kit enables detection of 12 mutations in the IDH1 and IDH2 genes using real-time PCR on the Rotor-Gene Q MDx 5plex HRM Instrument. The kit provides all necessary reagents, optimized for rapid and sensitive detection of IDH1 and IDH2 mutations.

Performance

See the therascreen IDH1/2 RGQ PCR Kit Handbook for detailed performance characteristics.

Principle

The therascreen IDH1/2 RGQ PCR Kit provides reagents to perform 9 separate amplification reactions for detection of 12 mutations:

  • 3 total amplification reactions of codons 132 and 100 of the IDH1 gene and of codon 172 of the IDH2 gene
  • 3 mutation amplification reactions of codons 132 and 100 of the IDH1 gene and of codon 172 of the IDH2 gene
  • 3 mutation-specific amplification reactions of IDH1 R132H, IDH1 R132C, and IDH2 R172K mutations

IDH1 and IDH2 mutations detected using the therascreen IDH1/2 RGQ PCR Kit
Gene Mutation Base change Cosmic ID

IDH1
Arg132His (R132H 395G>A COSM28746
Arg132Cys (R132C) 394C>T COSM28747
Arg132Ser (R132S) 394C>A COSM28748
Arg132Gly (R132G) 394 C>G COSM28749
Arg132Leu (R132L) 395G>T COSM28750
Arg132Val (R132V) 394_395 CG>GT COSM28751
Arg100Gln (R100Q) 299G>A COSM88208

IDH2
Arg172Lys (R172K) 515G>A COSM33733
Arg172Met (R172M) 515G>T COSM33732
Arg172Trp (R172W) 514A>T COSM34039
Arg172Ser (R172S) 516G>T COSM34090
Arg172Gly (R172G) 514A>G COSM33731

Total reaction mixes

The Total Primers and Probe Mixes (PPM-Total) use primers and probes to amplify both mutated and wild-type target sequences.

Mutation detection reaction mixes

The mutation detection primers and probe mixes combine primers and probes, to amplify both mutated and wild-type target sequences, plus an oligonucleotide, 3' blocked with the addition of a phosphate group to prevent elongation (PCR clamping), which is specific to the wild-type target sequence.

When the PCR template contains the wild-type sequence, the 3'-phosphate oligonucleotide will dominate over PCR primer binding due to higher affinity. There is no or low extension by the DNA polymerase and no or low amplification is observed.

When a mutated sequence is present, PCR primer binding will dominate over the 3'-phosphate oligonucleotide binding and amplification will proceed.

Mutation identification reaction mixes

Allele-specific amplification is achieved by ARMS (Amplification Refractory Mutation System), which exploits the ability of the DNA polymerase to distinguish between a match and a mismatch at the 3' end of a PCR primer.

When the PCR primer is fully matched, the amplification proceeds with full efficiency. When the 3' base is mismatched, only low-level background amplification occurs.

Procedure

The therascreen IDH1/2 RGQ PCR Kit provides all necessary reagents for detection of 12 mutations in the IDH1 and IDH2 genes. Nine primer and probe mixes are used to amplify both mutated and wild-type target sequences. Simply add template DNA and the appropriate primer and probe mix to the ready-to-use PCR master mix, and start the reaction on the Rotor-Gene Q MDx 5plex HRM instrument using the optimized cycling program described in the kit handbook. For DNA purification, we recommend using the QIAsymphony DNA Mini Kit on the QIAsymphony SP or the QIAamp DNA FFPE Tissue Kit, following the modified protocols given in the therascreen IDH1/2 RGQ PCR Kit Handbook.

Applications

The therascreen IDH1/2 RGQ PCR Kit is an in vitro diagnostic test based on PCR technology intended for the qualitative detection of 7 mutations in the IDH1 gene and 5 mutations in the IDH2 gene, and for direct identification of 3 major mutations, in DNA extracted from formalin-fixed, paraffin-embedded (FFPE) human brain tissue.
The therascreen IDH1/2 RGQ PCR Kit is intended to be used as an aid for the classification of gliomas.

Supporting data and figures

Resources

Kit Handbooks (1)
For detection of 12 IDH1 and IDH2 mutations in glioma
Safety Data Sheets (1)
Download Safety Data Sheets for QIAGEN product components.
Certificates of Analysis (1)

FAQ

What technologies are used by the therascreen PCR kits?
The mutations in the therascreen PCR kits are detected with high sensitivity using the Amplification Refractory Mutation System (ARMS). PCR is used to amplify the mutation, and amplification is signalled using Scorpions technology. Further information on these technologies can be obtained from QIAGEN Technical Service.
FAQ ID -2287